Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 5/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 3/20 | 1.00 |
| ▸ | MMP2 | P08253 | 2/20 | 1.00 |
| ▸ | MMP8 | P22894 | 2/20 | 1.00 |
| ▸ | APP | P05067 | 10/20 | 0.82 |
| ▸ | MAPT | P10636 | 9/20 | 0.82 |
| ▸ | BACE1 | P56817 | 5/20 | 0.82 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.82 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.82 |
| ▸ | TSHR | P16473 | 2/20 | 0.82 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.82 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.82 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.82 |
| ▸ | MAOA | P21397 | 2/20 | 0.82 |
| ▸ | MAOB | P27338 | 2/20 | 0.82 |
| ▸ | MMP13 | P45452 | 2/20 | 0.82 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.82 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.82 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.82 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12565705 | 1.00 | MMP9 (1.00) | MMP9NFKB1MMP2MMP8APP | |
| SCHEMBL13125782 | 1.00 | MMP9 (1.00) | MMP9NFKB1MMP2MMP8APP | |
| SCHEMBL16203057 | 1.00 | MMP9 (1.00) | MMP9NFKB1MMP2MMP8APP | |
| SCHEMBL6847537 | 0.91 | MMP9 (0.84) | MMP9NFKB1MMP2MMP8APP | |
| SCHEMBL13453148 | 0.91 | MMP9 (0.84) | MMP9NFKB1MMP2MMP8APP | |
| SCHEMBL26397843 | 0.91 | MMP9 (0.84) | MMP9NFKB1MMP2MMP8APP | |
| SCHEMBL13324431 | 0.91 | NFKB1 (0.83) | MMP9NFKB1MMP2MMP8APP | |
| Curcumin SCHEMBL8336603 | 0.90 | APP (1.00) | MMP9NFKB1MMP2MMP8APP | |
| Curcumin SCHEMBL8440 | 0.90 | APP (1.00) | MMP9NFKB1MMP2MMP8APP | |
| Curcumin SCHEMBL250984 | 0.90 | APP (1.00) | MMP9NFKB1MMP2MMP8APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029706-B2 | Methods for treating mucopolysaccharidosis | UNIVERSITY OF MIAMI (US) | 2024-07-09 | — | — | US | disclosed |
| US-11872236-B2 | Pharmacological agents for treating ocular diseases | CALASIA PHARMACEUTICALS, INC. (US) | 2024-01-16 | — | — | US | disclosed |
| US-20230400771-A1 | ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD | FUJIFILM CORPORATION (JP) | 2023-12-14 | — | — | US | disclosed |
| US-11839637-B2 | Neuron activator | KINJIRUSHI CO., LTD. (JP) | 2023-12-12 | — | — | US | disclosed |
| US-20230285573-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. | 2023-09-14 | — | — | US | disclosed |
| US-11744840-B2 | N-palmitoyl-D-glucosamine in a micronized form | INNOVET ITALIA S.R.L. (IT) | 2023-09-05 | — | — | US | disclosed |
| US-20230226814-A1 | ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD | FUJIFILM CORPORATION (JP) | 2023-07-20 | — | — | US | disclosed |
| US-20230190839-A1 | COMPOSITIONS AND COMBINATIONS FOR SUBJECTS SUFFERING FROM ENDOMETRIOSIS | GYNOV (FR) | 2023-06-22 | — | — | US | disclosed |
| US-20230161247-A1 | ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD | FUJIFILM CORPORATION (JP) | 2023-05-25 | — | — | US | disclosed |
| US-20180078535-A1 | THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF | IONS PHARMACEUTICAL S.À R.L. (LU) | 2018-03-22 | — | — | US | disclosed |
| US-20100260671-A1 | COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AMYLOID ASSOCIATED DISEASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-10-14 | — | — | US | disclosed |
| US-20100216859-A1 | CURCUMIN ANALOG COMPOSITIONS AND RELATED METHODS | CHARLESSON, LLC | 2010-08-26 | — | — | US | disclosed |
| US-20100190978-A1 | METHYLENE BLUE - CURCUMIN ANALOG FOR THE TREATMENT OF ALZHEIMER'S DISEASE | CODMAN & SHURTLEFF, INC. | 2010-07-29 | — | — | US | disclosed |
| US-7745670-B2 | Curcumin-Resveratrol hybrid molecule | CODMAN & SHURTLEFF, INC. (US) | 2010-06-29 | — | — | US | disclosed |
| US-7723515-B1 | Methylene blue—curcumin analog for the treatment of alzheimer's disease | CODMAN & SHURTLEFF, INC. (US) | 2010-05-25 | — | — | US | disclosed |
| US-20090326275-A1 | USE OF NITROGEN-CONTAINING CURCUMIN ANALOGS FOR THE TREATMENT OF ALZHEIMERS DISEASE | DEPUY SPINE, LLC | 2009-12-31 | — | — | US | disclosed |
| US-20090325963-A1 | Iontophoretic Delivery of Curcumin and Curcumin Analogs for the Treatment of Alzheimer's Disease | CODMAN & SHURTLEFF, INC. | 2009-12-31 | — | — | US | disclosed |
| US-20090087385-A1 | Intranasally administering curcumin in a bolus of helium gas to treat alzheimers disease | CODMAN & SHURTLEFF, INC. | 2009-04-02 | — | — | US | disclosed |
| US-20070204412-A1 | Curcumin and its derivatives for use as silicone colorants | GELEST, INC. (US) | 2007-09-06 | — | — | US | disclosed |
| US-20070204412-A1 | Curcumin and its derivatives for use as silicone colorants | GELEST, INC. (US) | 2007-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216859-A1 | CURCUMIN ANALOG COMPOSITIONS AND RELATED METHODS | PTGIS, HMOX1, PTGS1 | MMP9 63/4885NFKB1 42/4885MMP2 150/4885 |
| US-20100190978-A1 | METHYLENE BLUE - CURCUMIN ANALOG FOR THE TREATMENT OF ALZHEIMER'S DISEASE | APP, PSEN2, MAPT | MMP9 602/4885NFKB1 667/4885MMP2 862/4885 |
| US-20090326275-A1 | USE OF NITROGEN-CONTAINING CURCUMIN ANALOGS FOR THE TREATMENT OF ALZHEIMERS DISEASE | SLC1A3, SLC1A1, SLC1A2 | MMP9 2581/4885NFKB1 495/4885MMP2 3006/4885 |
| US-11744840-B2 | N-palmitoyl-D-glucosamine in a micronized form | NAPEPLD, FABP2, FSCN1 | MMP9 462/4885NFKB1 343/4885MMP2 619/4885 |
| US-20230285573-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | NEDD4, CBL, UBQLN2 | MMP9 4666/4885NFKB1 619/4885MMP2 3970/4885 |
| US-20180078535-A1 | THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF | INMT, HNMT, COMT | MMP9 2837/4885NFKB1 1602/4885MMP2 1432/4885 |
| US-20230190839-A1 | COMPOSITIONS AND COMBINATIONS FOR SUBJECTS SUFFERING FROM ENDOMETRIOSIS | SQSTM1, TSG101, SUCNR1 | MMP9 867/4885NFKB1 340/4885MMP2 1383/4885 |
| US-11872236-B2 | Pharmacological agents for treating ocular diseases | CRYAA, CRYAB, TTR | MMP9 3961/4885NFKB1 1082/4885MMP2 1302/4885 |
| US-12029706-B2 | Methods for treating mucopolysaccharidosis | GAA, MAN2B1, IDUA | MMP9 345/4885NFKB1 4698/4885MMP2 170/4885 |
| US-20100260671-A1 | COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AMYLOID ASSOCIATED DISEASES | APP, HTT, SCN3A | MMP9 3034/4885NFKB1 1948/4885MMP2 2728/4885 |
| US-11839637-B2 | Neuron activator | BDNF, DBH, CHAT | MMP9 2867/4885NFKB1 688/4885MMP2 2522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.